Amytrx Therapeutics, Inc.的封面图片
Amytrx Therapeutics, Inc.

Amytrx Therapeutics, Inc.

生物技术研究

Nashville,TN 1,040 位关注者

Advancing a new class of anti-inflammatory peptides to deliver breakthrough disease-altering therapies.

关于我们

Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients. Drawing on 25 years of research, Amytrx is harnessing the power of novel anti-inflammatory peptide discoveries to advance new medicines aimed at the prevention and treatment of inflammatory diseases. Our lead therapeutic candidate, AMTX-100, is bioengineered from human protein sequences that modulate the immune system by a natural process, reducing pathogenesis in a range of chronic diseases mediated by excessive inflammation. Joining forces with institutions for clinical research, Amytrx Therapeutics is dedicated to transforming the conventional treatment of chronic inflammatory diseases using biological technology that is easily understood by the human body in a way that is safe, effective, and simple to use.

网站
https://www.amytrx.com/
所属行业
生物技术研究
规模
2-10 人
总部
Nashville,TN
类型
私人持股

地点

Amytrx Therapeutics, Inc.员工

动态

相似主页

查看职位

融资

Amytrx Therapeutics, Inc. 共 2 轮

上一轮

A 轮

US$18,000,000.00

Crunchbase 上查看更多信息